39 related articles for article (PubMed ID: 16750359)
1. Synthesis and structure-activity studies of benzyl ester meperidine and normeperidine derivatives as selective serotonin transporter ligands.
Gu X; Izenwasser S; Wade D; Housman A; Gulasey G; Rhoden JB; Savoie CD; Mobley DL; Lomenzo SA; Trudell ML
Bioorg Med Chem; 2010 Dec; 18(23):8356-64. PubMed ID: 20980153
[TBL] [Abstract][Full Text] [Related]
2. The medicinal chemistry of piperazines: A review.
Faizan M; Kumar R; Mazumder A; Salahuddin ; Kukreti N; Kumar A; Chaitanya MVNL
Chem Biol Drug Des; 2024 Jun; 103(6):e14537. PubMed ID: 38888058
[TBL] [Abstract][Full Text] [Related]
3. Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 inhibitors.
MartÃnez R; Geronimo BD; Pastor M; Zapico JM; Coderch C; Panchuk R; Skorokhyd N; Maslyk M; Ramos A; de Pascual-Teresa B
Molecules; 2020 Mar; 25(7):. PubMed ID: 32218358
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues.
Wallach J; Kang H; Colestock T; Morris H; Bortolotto ZA; Collingridge GL; Lodge D; Halberstadt AL; Brandt SD; Adejare A
PLoS One; 2016; 11(6):e0157021. PubMed ID: 27314670
[TBL] [Abstract][Full Text] [Related]
5. Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors.
Guerrant W; Patil V; Canzoneri JC; Oyelere AK
J Med Chem; 2012 Feb; 55(4):1465-77. PubMed ID: 22260166
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review.
Siddiqui N; Andalip ; Bawa S; Ali R; Afzal O; Akhtar MJ; Azad B; Kumar R
J Pharm Bioallied Sci; 2011 Apr; 3(2):194-212. PubMed ID: 21687347
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.
Schatzberg AF
J Clin Psychiatry; 2003; 64 Suppl 13():30-7. PubMed ID: 14552654
[TBL] [Abstract][Full Text] [Related]
8. The treatment of urinary incontinence with Duloxetine.
Basu M; Duckett J
J Obstet Gynaecol; 2008 Feb; 28(2):166-9. PubMed ID: 18393011
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.
Fray MJ; Bish G; Fish PV; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2006 Aug; 16(16):4349-53. PubMed ID: 16750363
[TBL] [Abstract][Full Text] [Related]
10. Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors.
Wen H; Qin W; Yang G; Guo Y
Molecules; 2019 Jan; 24(3):. PubMed ID: 30704101
[TBL] [Abstract][Full Text] [Related]
11. Second generation N-(1,2-diphenylethyl)piperazines as dual serotonin and noradrenaline reuptake inhibitors: improving metabolic stability and reducing ion channel activity.
Fray MJ; Fish PV; Allan GA; Bish G; Clarke N; Eccles R; Harrison AC; Le Net JL; Phillips SC; Regan N; Sobry C; Stobie A; Wakenhut F; Westbrook D; Westbrook SL; Whitlock GA
Bioorg Med Chem Lett; 2010 Jun; 20(12):3788-92. PubMed ID: 20471260
[TBL] [Abstract][Full Text] [Related]
12. Duloxetine (Cymbalta), a dual inhibitor of serotonin and norepinephrine reuptake.
Bymaster FP; Beedle EE; Findlay J; Gallagher PT; Krushinski JH; Mitchell S; Robertson DW; Thompson DC; Wallace L; Wong DT
Bioorg Med Chem Lett; 2003 Dec; 13(24):4477-80. PubMed ID: 14643350
[TBL] [Abstract][Full Text] [Related]
13. N-Benzyl-N-(tetrahydro-2H-pyran-4-yl)pyrrolidin-3-amines as selective dual serotonin/noradrenaline reuptake inhibitors.
Fish PV; Fray MJ; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2007 Apr; 17(7):2022-5. PubMed ID: 17267217
[TBL] [Abstract][Full Text] [Related]
14. N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.
Jonathan Fray M; Bish G; Brown AD; Fish PV; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2006 Aug; 16(16):4345-8. PubMed ID: 16750359
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
